GPRASP1 and prostate carcinoma: In our limited-sample-size analysis, GASP-1 IHC could be used to differentiate early and more advanced prostate cancer (such as between Gleason Grades 3 and Gleason Grades 4 and 5) with a p value of 0.0004 (see columns 4 and 5 of Figure 2).